News from sensus healthcare A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 18, 2019, 13:15 ET Sei Bello Plastic Surgeon in North Atlanta Adopts Sensus Healthcare's Groundbreaking Superficial Radiation Therapy for Keloid Treatment

Sei Bello, a plastic surgery center in Lawrenceville, Ga., announced today its adoption of Sensus Healthcare's Superficial Radiation Therapy, or SRT, ...


May 08, 2019, 08:30 ET Sensus Healthcare Awarded Brachytherapy Products Agreement with Premier

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in novel radiation oncology technologies and solutions, has been...


Apr 25, 2019, 16:00 ET Sensus Healthcare to Host First Quarter 2019 Financial Results and Business Update Conference Call on May 9, 2019

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...


Apr 23, 2019, 08:30 ET Five-Year Retrospective Study Shows 98.9 Percent Cure Rate for Non-Melanoma Skin Cancer Patients Treated with Sensus Healthcare's Superficial Radiation Therapy

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in non-invasive treatments for both oncological and non-oncological...


Feb 28, 2019, 08:00 ET Sensus Healthcare Appoints Dr. Ziv Karni as Chief Scientific Officer

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and...


Feb 14, 2019, 16:02 ET Sensus Healthcare Fourth Quarter Financial Results Feature Record Revenue and Continued Double-digit Growth

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Feb 14, 2019, 08:30 ET Leading Dermatologists Develop Consensus Guidelines for the Use of Superficial Radiation Therapy to Treat Non-Melanoma Skin Cancers and Keloids

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...


Feb 12, 2019, 08:45 ET Cure Rate Exceeds 97 Percent in Retrospective Study of Sensus Healthcare's SRT-100™ for Treating Basal and Squamous Cell Carcinomas of the Lower Extremities

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...


Nov 01, 2018, 16:02 ET Sensus Healthcare Third Quarter Financial Results Feature Revenue Growth of 32%

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Oct 22, 2018, 08:30 ET Sensus Healthcare to Host Third Quarter 2018 Financial Results and Business Update Conference Call on November 1, 2018

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Oct 16, 2018, 08:30 ET South Florida Business Journal Recognizes Sensus Healthcare's Chief Technology Officer at 2018 Technology Awards

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...


Sep 21, 2018, 11:06 ET Sensus Healthcare, Inc. Announces Underwriters' Exercise of Option

Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has issued an additional 330,882 shares of its common stock pursuant to the exercise...


Sep 13, 2018, 09:28 ET Sensus Healthcare, Inc. Announces Pricing of Public Offering of Common Stock

Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it has priced an underwritten public offering of 2,205,882 shares of its common stock,...


Aug 27, 2018, 08:00 ET Sensus Healthcare to Participate in Two Upcoming Investor Conferences

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Aug 02, 2018, 09:28 ET Sensus Healthcare Receives FDA 510(k) Clearance to Market Next-Generation SRT-100+ Superficial Radiation Therapy for Treating Non-Melanoma Skin Cancer and Keloids

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...


Jul 31, 2018, 08:00 ET Sensus Healthcare CEO Receives "Innovator of the Year" Award at The Aesthetic Show 2018

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and...


Jul 10, 2018, 08:00 ET Sensus Healthcare and CellMark Medical Partner to Accelerate International Expansion and Growth for Innovative Oncology and Aesthetic Solutions

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


May 08, 2018, 08:30 ET Sensus Healthcare Appoints Dr. Isabelle Raymond as Vice President, Clinical Development

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


May 01, 2018, 08:30 ET Sensus Healthcare Appoints Rita Gable as Vice President of Sales - Oncology

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Apr 19, 2018, 08:30 ET Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Mar 08, 2018, 08:30 ET Sensus Healthcare to Present at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Mar 05, 2018, 08:30 ET Sensus Healthcare Launches New Line of Laser Systems to Provide Patients with Full Spectrum of Clinical and Aesthetic Dermatological Solutions

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Feb 07, 2018, 08:30 ET Sensus Healthcare Opens Tel Aviv Office to Expand Footprint in Israel, the Middle East & Europe

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Feb 05, 2018, 08:32 ET Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World

Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...


Feb 01, 2018, 04:01 ET Sensus Healthcare Reports Record Revenue for 2017 Fourth Quarter and Full Year

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids...